BusinessCocrystal Pharma Receives FDA Clearance to Initiate Phase 2a Clinical Study Evaluating CC-31244 for the Treatment of Hepatitis C VirusBy Nasdaq OMXApr 3, 2018, 12:01 PM UTC
BusinessCocrystal Pharma Reports 2017 Financial Results and Provides Corporate Overview and Business OutlookBy Nasdaq OMXMar 22, 2018, 11:05 AM UTC
BusinessOverstock.com CEO Dr. Patrick M. Byrne to Take Medical Leave of AbsenceBy Nasdaq OMXApr 11, 2016, 10:41 AM UTC
